About the Journal
Aims and Scope
Journal of Immunotherapy and Precision Oncology (JIPO) is a peer-reviewed, open-access journal that is published by the Innovative Healthcare Institute (Cincinnati, OH, USA) (innovativehci.com).
JIPO publishes high-quality manuscripts related to the field of immunotherapy and precision oncology. The content appeals to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. The scope of the Journal includes translational science and preclinical and clinical medicine. Article types include original research articles, brief reports of new research, comprehensive review articles and meta-analyses, case reports, and more.
Manuscripts related to preclinical, clinical, and translational discoveries related with immunity and cancer and immunotherapy, such as new discoveries about immune system function and biology, new therapeutic approaches to different malignancies, mechanisms of resistance, clinical assessment, and more will be considered for publication. Subjects related to precision oncology including prognostic or predictive markers and innovative targeted therapy advances in diagnostic technology will also be considered. High quality evidence-based guidelines of credible professional entities will also be considered for publication.
Indexing
JIPO is indexed by Web of Science, PubMed Central (PMC), Scopus, Embase, Directory of Open Access Journals (DOAJ), and Crossref.
